At least, on paper.

By Diederik StadigUS President Donald Trump signed a new executive order on 15 April aimed at bringing US drug prices down.

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

The University of Wyoming has once again made the list of the National Academy of Inventors’ (NAI) top 100 universities in the U.S. with the most patents granted.

A former federal employee who worked for the Patent and Trademark Office in the Department of Commerce was convicted this week for possession of child sexual ...

An U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

The litigation was initiated by Astellas Pharma against Zydus Lifesciences concerning the validity of the ‘780 patent’, which ...

The United States Court of Appeals for the Federal Circuit dismissed a legal claim against the NFL’s New Orleans Saints from ...

The Commerce Department and its National Oceanic and Atmospheric Administration (NOAA) are already refiring probationary ...

Opinion: Eversheds Sutherland attorneys Michael Bahar, Mary Jane Wilson-Bilik, and Alexander Fuchs warn companies that ...

The probe into semiconductors, pharmaceuticals, and critical minerals will impact India apart from China. Pharmaceuticals and ...